# OnCo record celltrion (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/celltrion/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "celltrion" ;
  schema:name "Celltrion"@en ;
  schema:description "Celltrion is a South Korea-based pharmaceutical company running 2 late-stage cancer trials of CT-P51 and CT-P44(Daratumumab) in non-small-cell lung cancer and multiple myeloma."@en ;
  schema:url <https://onco.cc/companies/celltrion/>, <https://www.celltrion.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.celltrion.com>, <https://clinicaltrials.gov/search?lead=Celltrion> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:trials <https://onco.cc/trials/nct06952478/>, <https://onco.cc/trials/nct06939595/> .
